Innoveren Scientific Inc. (IVRN)

Market Cap	1.60K
Revenue (ttm)	n/a
Net Income (ttm)	-3.26M
Shares Out	8.01M
EPS (ttm)	-5.51
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,300
Average Volume	46,383
Open	0.0002
Previous Close	n/a
Day's Range	0.0002 - 0.0002
52-Week Range	n/a
Beta	482.13
RSI	33.92
Earnings Date	Aug 12, 2025

About Innoveren Scientific

Innoveren Scientific Inc., a medical bioscience company that develops technology in regenerative medicine for limb salvage. It is also developing immunotherapies for ovarian cancer, pancreatic cancer, and mesothelioma. The company was formerly known as H-CYTE, Inc. and changed its name to Innoveren Scientific Inc. in July 2023. The company is headquartered in Tampa, Florida.

• Industry: Biotechnology
• Sector: Healthcare
• CEO: Michael Yurkowsky
• Employees: 2
• Stock Exchange: OTCMKTS
• Ticker Symbol: IVRN

Financial Performance

In 2022, Innoveren Scientific's revenue was $453,460, a decrease of -71.86% compared to the previous year's $1.61 million. Losses were -$10.30 million, 114.6% more than in 2021.